Roche: European Commission Approves Xofluza For Children Aged One Year And Above

Roche (RHHBY) announced the European Commission has approved Xofluza in children aged one year and above for the treatment of uncomplicated influenza and for post-exposure prophylaxis of influenza. The approval is based on the results of the phase III miniSTONE-2 and BLOCKSTONE studies.

Xofluza was first approved for use in Europe in 2021 for the treatment of uncomplicated influenza and for post-exposure prophylaxis of influenza in adults and adolescents aged 12 years and above. The company is continuing to investigate Xofluza in phase III trials in children under the age of one.

For More Such Health News, visit rttnews.com.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
A group of 23 U.S. states attorneys general have asked South Korean car manufacturers Hyundai Motor and Kia Corp. to take action more quickly to solve problems with millions of U.S. vehicles facing theft. The issue is related to the companies' failure to equip vehicles with anti-theft immobilizers, which has been a standard equipment on vehicles sold by other major manufacture El Monte, California-based Mutual Trading Co., Inc. is recalling certain Kagome Sauces citing undeclared soy, a known allergen, the U.S. Food and Drug Administration said. The recall involves 60 fl oz of Kagome Worcester Sauce, 10 fl oz of Kagome Chuno sauce, and 8g of Kagome Take out Tonkatsu Sauce. With a view to celebrate college basketball season, Domino's Pizza Inc. is offering customers 50% off all menu-priced pizzas ordered online today through March 26. The weeklong 50% off online deal is available on menu-priced pizzas ordered through Domino's online ordering channels.
Follow RTT